You Say Goodbye, I Say Hello – MHRA Moves In, EMA Moves Out
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency is relocating to the very area in east London the European Medicines Agency is being forced to abandon.
You may also be interested in...
Brexit: How The UK MHRA And Its EU Roles Could Be Affected
The UK MHRA’s latest annual report reveals how much income the agency receives for activities it carries out on behalf of the European Medicines Agency, and looks among other things at how the MHRA should address the challenges raised by Brexit.
EU Postpones Decision On EMA’s New Home To November
The decision on where the European Medicines Agency should be located after the UK leaves the EU has been postponed to November. The European Council has published details of the bidding process countries must follow if they want to host the EMA.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add a new product – Tibsovo, Servier’s treatment for IDH1-mutated acute myeloid leukemia and IDH1-mutated cholangiocarcinoma.